Get the Stockscreener App
2.50
13.49%
-0.39
After Hours:
2.50
Intelligent Bio Solutions Inc stock is currently priced at $2.50, with a 24-hour trading volume of 175.34K.
It has seen a -13.49% decreased in the last 24 hours and a -34.04% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $2.78 pivot point. If it approaches the $2.28 support level, significant changes may occur.
Previous Close:
$2.89
Open:
$3.04
24h Volume:
175.34K
Market Cap:
$7.11M
Revenue:
$2.46M
Net Income/Loss:
$-13.40M
P/E Ratio:
-0.258
EPS:
-9.69
Net Cash Flow:
$-7.34M
1W Performance:
-5.66%
1M Performance:
-34.04%
6M Performance:
+1,001%
1Y Performance:
-5.66%
1D Range:
$2.40
$3.04
52W Range:
$0.19
$11.70
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Name
Intelligent Bio Solutions Inc
Sector
Industry
Phone
646 828 8258
Address
142 West 57th Street, 11th Floor, New York
Intelligent Bio Solutions Inc Stock (INBS) Latest News
Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC
GlobeNewswire Inc.
Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024
GlobeNewswire Inc.
Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway
GlobeNewswire Inc.
Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders’ Equity Requirement
GlobeNewswire Inc.
Intelligent Bio Solutions Inc Stock (INBS) Financials Data
Intelligent Bio Solutions Inc (INBS) Revenue 2024
INBS reported a revenue (TTM) of $2.46 million for the quarter ending December 31, 2023.
Intelligent Bio Solutions Inc (INBS) Net Income 2024
INBS net income (TTM) was -$13.40 million for the quarter ending December 31, 2023, a -165.71% decrease year-over-year.
Intelligent Bio Solutions Inc (INBS) Cash Flow 2024
INBS recorded a free cash flow (TTM) of -$7.34 million for the quarter ending December 31, 2023, a -2.32% decrease year-over-year.
Intelligent Bio Solutions Inc (INBS) Earnings per Share 2024
INBS earnings per share (TTM) was -$128.88 for the quarter ending December 31, 2023, a +8.67% growth year-over-year.
About Intelligent Bio Solutions Inc
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
4.49%
Cap:
|
Volume (24h):